Metformin (generic), Glucophage News

African Americans taking the diabetes drug Metformin saw greater improvements in their blood sugar control than white individuals who were prescribed the same medication, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism .

The oral medicine metformin is more effective at controlling blood glucose levels in African-Americans than in whites, according to new research published in The Journal of Endocrinology and Metabolism.

Pharmacologic management of hyperglycemia associated with type 2 diabetes mellitus can be complex and challenging for both healthcare providers and patients.1 A wide array of treatment options are available, starting with lifestyle modifications and metformin monotherapy and progressing to two- and three-drug combinations that may or may not ... (more)

The Journal of clinical endocrinology and metabolism , Vol. 98, No. 2. , pp. 668-677, doi:10.1210/jc.2012-3042 The safety of insulin in the treatment of type 2 diabetes mellitus has recently undergone scrutiny.

Controlling blood sugar levels may be a lot easier for diabetics as researchers have discovered that consuming whey protein before a regular breakfast reduces the blood sugar spikes seen after meals.

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition ... (more)

To conduct a systematic review and meta-analysis of pregnancy outcome after metformin use for polycystic ovary syndrome , because the efficacy of metformin has been demonstrated in the treatment of infertility caused by PCOS, whereas the fetal safety of metformin has received very little attention, and the few studies addressing this issue are ... (more)

Metformin is generally considered a non-teratogenic drug; however, only a few studies specifically designed to assess the rate of congenital anomalies after metformin use have been published in the literature.

NuSirt Biopharma, Inc., today announced that two papers presented at the American Diabetes Association 74th Scientific Sessions demonstrate that the company's patented technology enhances the ability of a common Type 2 diabetes medication to better control blood sugar.

The American Diabetes Association will present their 74th Scientific Sessions event on June 13-17, 2014.

Caloric restriction: In moderation, limiting caloric intake has been shown to lower the incidence of aging-related deaths in many strains of mice and rats and in rhesus monkeys, reducing the incidence of diabetes, cancer, cardiovascular disease and brain atrophy.

Many inaccurate statements are being made about the drug label attached to Afrezza as part of Friday's approval of the drug.

Meijer pharmacies marked a major milestone this month when one of the retailer's pharmacists dispensed the 20 millionth free customer prescription through its free prescription program.

Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.

N Engl J Med In New England Journal of Medicine, Vol. 346, No. 6. , pp. 393-403, doi:10.1056/nejmoa012512 Background Type 2 diabetes affects approximate- ly 8 percent of adults in the United States.

BANGALORE: By adopting the latest lifestyles many of the people have become prey to several diseases like diabetes.

The American Diabetes Association will present their 74th Scientific Sessions event on June 13-17, 2014.

ROCHESTER, Minn. - Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes.

In addition to healthy eating, being at a normal weight and being active, medications play an important role in the management of diabetes.

Treatments used to decrease the development of type 2 diabetes continue to be effective an average of 15 years later, according to the latest findings of the Diabetes Prevention Program Outcomes Study, a landmark study funded by the National Institutes of Health .